Suppr超能文献

血管紧张素受体信号激活、配体选择性和变构调节机制的结构观点:国际药理学联合会评论 34。

Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric modulation in angiotensin receptors: IUPHAR Review 34.

机构信息

Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Br J Pharmacol. 2022 Sep;179(18):4461-4472. doi: 10.1111/bph.15840. Epub 2022 Apr 23.

Abstract

Functional advances have guided our knowledge of physiological and fatal pathological mechanisms of the hormone angiotensin II (AngII) and its antagonists. Such studies revealed that tissue response to a given dose of the hormone or its antagonist depends on receptors that engage the ligand. Thus, we need to know much more about the structures of receptor-ligand complexes at high resolution. Recently, X-ray structures of both AngII receptors (AT and AT receptors) bound to peptide and non-peptide ligands have been elucidated, providing new opportunities to examine the dynamic fluxes in the 3D architecture of the receptors, as the basis of ligand selectivity, efficacy, and regulation of the molecular functions of the receptors. Constituent structural motifs cooperatively transform ligand selectivity into specific functions, thus conceptualizing the primacy of the 3D structure over individual motifs of receptors. This review covers the new data elucidating the structural dynamics of AngII receptors and how structural knowledge can be transformative in understanding the mechanisms underlying the physiology of AngII.

摘要

功能进展指导了我们对激素血管紧张素 II(AngII)及其拮抗剂的生理和致命病理机制的认识。这些研究表明,组织对给定剂量的激素或其拮抗剂的反应取决于与配体结合的受体。因此,我们需要更多地了解受体-配体复合物在高分辨率下的结构。最近,已经阐明了与肽和非肽配体结合的两种 AngII 受体(AT 和 AT 受体)的 X 射线结构,为检查受体三维结构中的动态通量提供了新的机会,这是配体选择性、效力和受体分子功能调节的基础。组成结构基序协同地将配体选择性转化为特定功能,从而将 3D 结构置于受体的单个基序之上。这篇综述涵盖了阐明 AngII 受体结构动力学的新数据,以及结构知识如何在理解 AngII 生理学的机制方面具有变革性。

相似文献

3
Angiotensin II cyclic analogs as tools to investigate ATR biased signaling mechanisms.
Biochem Pharmacol. 2018 Aug;154:104-117. doi: 10.1016/j.bcp.2018.04.021. Epub 2018 Apr 20.
4
Differential beta-arrestin binding of AT1 and AT2 angiotensin receptors.
FEBS Lett. 2006 Jan 9;580(1):41-5. doi: 10.1016/j.febslet.2005.11.044. Epub 2005 Dec 6.
6
Angiotensin II receptors' modulation of calcium homeostasis in human vascular endothelial cells.
Can J Physiol Pharmacol. 2017 Oct;95(10):1289-1297. doi: 10.1139/cjpp-2017-0416. Epub 2017 Jul 21.
7
8
Computational approaches on angiotensin receptors and their ligands: recent developments and results.
Curr Med Chem. 2007;14(29):3105-21. doi: 10.2174/092986707782793970.
9
Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles.
Cell Signal. 2011 Nov;23(11):1767-76. doi: 10.1016/j.cellsig.2011.06.011. Epub 2011 Jun 25.
10

引用本文的文献

1
Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors.
Molecules. 2025 May 30;30(11):2399. doi: 10.3390/molecules30112399.
2
Analysis of peri-implant bone tissue between hydrophilic and rough implant surfaces in spontaneously hypertensive rats treated with losartan.
J Appl Oral Sci. 2024 Jun 24;32:e20230374. doi: 10.1590/1678-7757-2023-0374. eCollection 2024.
4
The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.
Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281.

本文引用的文献

1
Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers.
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33). doi: 10.1073/pnas.2019126118.
3
Highly accurate protein structure prediction with AlphaFold.
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
4
Structural insights into ligand recognition and activation of angiotensin receptors.
Trends Pharmacol Sci. 2021 Jul;42(7):577-587. doi: 10.1016/j.tips.2021.04.006. Epub 2021 May 10.
5
Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD.
Pharmacol Res. 2020 Nov;161:105223. doi: 10.1016/j.phrs.2020.105223. Epub 2020 Oct 2.
6
Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR.
Science. 2020 Feb 21;367(6480):888-892. doi: 10.1126/science.aay9813.
7
Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor.
Science. 2020 Feb 21;367(6480):881-887. doi: 10.1126/science.aaz0326.
8
The Crystal Structure of Angiotensin II Type 2 Receptor with Endogenous Peptide Hormone.
Structure. 2020 Apr 7;28(4):418-425.e4. doi: 10.1016/j.str.2019.12.003. Epub 2019 Dec 30.
9
Common activation mechanism of class A GPCRs.
Elife. 2019 Dec 19;8:e50279. doi: 10.7554/eLife.50279.
10
Angiotensin Type 1 Receptor Blockers in Heart Failure.
Curr Drug Targets. 2020;21(2):125-131. doi: 10.2174/1389450120666190821152000.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验